#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	3892	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2431	477.4	0	.	n	.	0	A662G	SNP	662	662	A	1098	1098	G	596	G,A,T	510,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	3892	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2431	477.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	1886	1886	T	575	T,C	522,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	3892	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2431	477.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1620	1620	C	565	C	490	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6754	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3835	528.0	0	.	n	.	0	G262A	SNP	262	262	G	734	734	A	613	A	529	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6754	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3835	528.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1809	1809	A	592	A,G	529,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6754	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3835	528.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2443	2443	C	621	C	546	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6754	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3835	528.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2517	2517	A	668	A,G,C	569,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6754	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3835	528.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	3069	3069	C	611	C,A	526,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	528	folP	852	852	99.77	folP.l6.c17.ctg.1	1839	86.0	0	.	p	.	0	S68P	NONSYN	202	204	TCG	697	699	CCG	115;116;116	C;C;G	96;95;96	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	528	folP	852	852	99.77	folP.l6.c17.ctg.1	1839	86.0	0	.	p	.	0	A204V	NONSYN	610	612	GCA	1105	1107	GTA	111;110;111	G;T,G;A	100;100,1;101	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	528	folP	852	852	99.77	folP.l6.c17.ctg.1	1839	86.0	1	SNP	p	R228S	1	.	.	682	684	AGC	1177	1179	AGC	115;114;115	A;G;C	109;108;107	folP.WHO_X_01360c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1180	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3702	95.4	1	SNP	p	S91F	0	.	.	271	273	TCC	746	748	TCC	97;97;96	T;C;C	83;81;81	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1180	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3702	95.4	1	SNP	p	D95G	0	.	.	283	285	GAC	758	760	GAC	89;90;91	G;A;C	81;80;81	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1180	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3702	95.4	1	SNP	p	D95N	0	.	.	283	285	GAC	758	760	GAC	89;90;91	G;A;C	81;80;81	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	27	464	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1674	83.2	1	SNP	p	G45D	0	.	.	133	135	GGC	651	653	GGC	114;114;114	G;G;C	103;105;104	mtrR.WHO_U_01459:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	288	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1291	67.1	0	.	n	.	0	.206T	INS	206	206	T	732	732	T	115	T	98	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	1154	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3318	104.4	0	.	p	.	0	G459S	NONSYN	1375	1377	GGT	1868	1870	AGT	133;135;135	A,G;G;T	109,1;111;111	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	1154	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3318	104.4	1	SNP	p	D86N	0	.	.	256	258	GAC	749	751	GAC	121;122;123	G;A;C	108;110;111	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	1154	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3318	104.4	1	SNP	p	S87W	0	.	.	259	261	AGT	752	754	AGT	122;121;121	A;G;T,A	110;110;106,1	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	1154	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3318	104.4	1	SNP	p	S87I	0	.	.	259	261	AGT	752	754	AGT	122;121;121	A;G;T,A	110;110;106,1	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	1154	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3318	104.4	1	SNP	p	S87R	0	.	.	259	261	AGT	752	754	AGT	122;121;121	A;G;T,A	110;110;106,1	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	1154	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3318	104.4	1	SNP	p	S88P	0	.	.	262	264	TCC	755	757	TCC	121;121;124	T;C;C	110;110;112	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1096	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3005	109.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1732	1734	GGC	151;151;152	G;G;C	127;124;125	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	1010	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2662	113.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1343	1345	GCA	148;149;149	G;C;A	124;126;127	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1010	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2662	113.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1346	1348	ATC	149;149;150	A;T;C	127;126;128	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1010	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2662	113.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1358	1360	GTG	147;144;143	G;T;G,A	126;122;123,1	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1010	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2662	113.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1358	1360	GTG	147;144;143	G;T;G,A	126;122;123,1	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1010	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2662	113.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1862	1864	ACC	143;143;144	A;C;C	126;125;126	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1010	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2662	113.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1916	1918	GCG	145;145;145	G,A;C;G	115,1;110;114	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1010	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2662	113.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1916	1918	GCG	145;145;145	G,A;C;G	115,1;110;114	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1010	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2662	113.6	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2039	2041	GGT	138;137;137	G,A;G;T	119,1;119;117	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1010	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2662	113.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2048	2050	GGC	132;132;131	G;G;C	114;115;114	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	1010	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2662	113.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2066	2068	CCG	130;131;131	C;C;G	108;115;113	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	1504	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3391	133.3	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1743	1745	CTG	165;166;166	C;T;G	141;141;136	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	562	porA	1146	1146	99.56	porA.l6.c4.ctg.1	2072	81.4	0	.	p	.	0	S22G	NONSYN	64	66	AGC	516	518	GGC	105;105;106	G;G;C	80;84;87	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	562	porA	1146	1146	99.56	porA.l6.c4.ctg.1	2072	81.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	698	698	C	100	C,T	88,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	782	porB1b	1041	1041	96.95	porB1b.l15.c30.ctg.1	1554	143.9	0	.	p	.	0	T18M	NONSYN	52	54	ACG	306	308	ATG	172;173;171	A;T;G	134;134;134	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	782	porB1b	1041	1041	96.95	porB1b.l15.c30.ctg.1	1554	143.9	0	.	p	.	0	T26A	NONSYN	76	78	ACC	330	332	GCC	170;169;170	G;C;C	134;136;134	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	782	porB1b	1041	1041	96.95	porB1b.l15.c30.ctg.1	1554	143.9	0	.	p	.	0	K41D	NONSYN	121	123	AAA	375	377	GAC	174;173;174	G;A;C	144;141;142	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	782	porB1b	1041	1041	96.95	porB1b.l15.c30.ctg.1	1554	143.9	0	.	p	.	0	G140R	NONSYN	418	420	GGA	672	674	AGA	151;151;153	A;G;A	135;133;133	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	782	porB1b	1041	1041	96.95	porB1b.l15.c30.ctg.1	1554	143.9	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	681	683	CAA	157;157;158	C,A;A;A	135,1;137;137	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	782	porB1b	1041	1041	96.95	porB1b.l15.c30.ctg.1	1554	143.9	0	.	p	.	0	I209M	NONSYN	625	627	ATC	879	881	ATG	150;150;154	A;T;G	127;125;130	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	782	porB1b	1041	1041	96.95	porB1b.l15.c30.ctg.1	1554	143.9	0	.	p	.	0	Y212fs	FSHIFT	634	634	T	888	888	T	155	T	128	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	2834	rpoB	4179	4179	100.0	rpoB.l15.c17.ctg.1	5200	163.7	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2147	2149	CAT	153;154;155	C;A;T	135;136;138	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	446	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1379	97.2	1	SNP	p	V57M	1	.	.	169	171	ATG	715	717	ATG	178;178;178	A;T;G	152;152;150	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
